|
Story |
Why Managed Care Is Getting A Bad Rap |
Peter Wehrwein |
|
Story |
Insurer's Wellness Effort Scores Good 5-Year Return |
Frank Diamond |
|
Story |
Why Falsify Records When Anonymity Can Be Had in a Tested, Familiar Way? |
Michael S. Victoroff, M.D. |
|
Story |
Key PBM Functional Areas Require Radical Transformation |
Warren K. Williams |
|
Story |
FDA Panel Likes New Treatment for Idiopathic Pulmonary Fibrosis |
Thomas Morrow, MD |
|
Story |
PBMs’ Rebate Income Threatened By Lawsuits and Move to Generics |
Martin Sipkoff |
|
Story |
‘Population-Based,’ Meet ‘Patient-Centered’ |
Timothy Kelley |
|
Story |
5 Threats To Value-Based Insurance Design |
Michael D. Dalzell |
|
Story |
Is Care Coordination Making Carve-outs Less Desirable? |
Martin Sipkoff |
|
Story |
Medicaid formularies manage conflicts of interest poorly |
webadmin |
|
Story |
Changing Payment Methodologies Force Physicians Into Larger Groups |
John Carroll |
|
Blog entry |
Separating Fact From Fiction: Are ACOs the Answer? |
gknorman |
|
Blog entry |
Doc Execs Give Consumer Ratings Sites an ‘F’ |
Frank Diamond |
|
Story |
Are You Prepared for ICD-10? |
Jillian Harrington, MHA |
|
Story |
Medication Therapy Management Program in N.C. Saves $13 Million |
Thomas Reinke |
|
Story |
Meaningful Use: Tasty Carrot or Big, Brutal Stick? |
John Carroll |
|
Story |
Lipitor Kicks Off Onslaught of Drug Patent Conversions |
Thomas Reinke |
|
Story |
Businesses Need Reasons To Stay in Coverage Game |
John Marcille |
|
Story |
Health Plans: Disrupt and Prosper |
Stephen Wunker |
|
Story |
Relapsing Multiple Sclerosis Patients Can Look to Second Oral Agent |
Thomas Morrow, MD |
|
Story |
Legislation Shortens Members’ Waiting Time |
John Carroll |
|
Story |
Questions About Coverage Accompany New Fully Implantable Hearing System |
Thomas Morrow, MD |
|
Story |
Pursuing a Bang for the Buck In the Battle of the Bulge |
Richard M. Kirkner |
|
Story |
Ohio Struggles To Rescue Managed Medicaid Program |
Bob Carlson |
|
Story |
FTC Antitrust Rules Offer Hope of Limiting ACO Market Power |
John Carroll |